Javier García-González Selected Research

Biological Therapy

10/2018

Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javier García-González Research Topics

Disease

6	Endocarditis 01/2023 - 01/2017
2	Rheumatic Diseases (Rheumatism) 09/2023 - 10/2018
1	Arthritis (Polyarthritis) 09/2023
1	Disease Progression 09/2023
1	Bacteremia 01/2023
1	Infections 01/2023
1	Panuveitis 02/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2018

Drug/Important Bio-Agent (IBA)

5	Daptomycin FDA Link 01/2023 - 01/2019
4	Vancomycin FDA LinkGeneric 01/2023 - 01/2017
2	Fosfomycin FDA Link 01/2023 - 12/2020
2	Cloxacillin (Tegopen)FDA Link 12/2021 - 12/2020
2	Gentamicins (Gentamicin)FDA LinkGeneric 12/2020 - 01/2019
1	Antirheumatic Agents (DMARD)IBA 09/2023
1	GlucocorticoidsIBA 09/2023
1	Methicillin (Metin)FDA Link 12/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Penicillins (Penicillin)FDA Link 01/2019
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2019
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2019

Therapy/Procedure

3	Therapeutics 09/2023 - 12/2021
1	Biological Therapy 10/2018